BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”), a fully integrated contract research and manufacturing organization offering laboratory, CMC and ...
Pfizer might be able to identify potential safety issues of drug candidates in early stages, as it has licensed a human cell line from Absorption Systems designed to do just that. What Pfizer has an ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. 'We look forward to an exciting future together.' Jazz ...
Beijing-based contract research and manufacturing company Pharmaron is paying $137.5 million in cash to buy up nonclinical CRO Absorption Systems. This sees the publicly listed Chinese CRMO broaden ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results